EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cistanche tubulosa improves peripheral neuropathy in MPTP ‐induced PD mice based on regulation of m6A methylation

Yatan Li iD, Wei Jia, Junhua Hu, Borui Zhang, Xinxin Qi, Jianhua Yang, Xinling Yang

Animal Models and Experimental Medicine · 2025

DOI: 10.1002/ame2.70039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, 2025. Verfasst von Yatan Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Second Affiliated Hospital, Xinjiang Medical University, Urumqi, China. Hauptthemen laut MEDLINE: Cistanche, Neuroprotective Agents, Peripheral Nervous System Diseases, Glucosides. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Xinjiang Uygur Autonomous Region Science and Technology Department- Tianshan Innovation Team Program Project, Xinjiang Uygur Autonomous Region Science and Technology Department- Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to discover whether Cistanche tubulosa affects the AKT/CASP3 pathway by regulating m6A methylation, to exert a protective effect against peripheral nerve injury in a Parkinson's Disease (PD) mouse model.

Methods

In this study, network pharmacology analysis and the molecular docking virtual screening technique was used to filter Acteoside (Act), a potential neuroprotective agent of active components in Cistanche tubulosa . A PD‐related peripheral neuropathy mouse model was established by MPTP induction, followed by 21 days treatment of oral Act (25, 50, and 100 mg kg −1 ). Pole climbing, automatic avoidance ability and hot plate sensory tests were evaluated to determine behavioral changes caused by central and peripheral nerve injury. The pathological alterations of dorsal root ganglion tissue and the protein levels of IL‐6, AKT, and CASP3 under Act intervention, as well as the dynamic changes of FTO, METTL3, and YTHDF2 which are closely related to m6A methylation, were comprehensively analyzed to observe the peripheral nerve protective efficacy of Act.

Results

The results showed that peripheral neuropathy occurring with PD in the mouse model, which could be verified by behavioral tests and pathological histological changes. In addition to the previously established protective effect of Act on dopaminergic neurons in substantia nigra (SN), extensive follow‐up studies demonstrated that Act effectively induced m6A methylation, which could further regulate the AKT/CASP3 pathway to play a therapeutic role. In this study, medium and high doses of Act played more obvious therapeutic roles.

Conclusion

These findings suggest that Act may regulate the severity of peripheral nerve injury under the activation of the AKT/CASP3 signaling pathway by balancing the methylation level of m6A. These results provide a theoretical basis and experimental evidence for further research on the protective effect of Cistanche tubulosa on both the central and peripheral nerves in the treatment of PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CistancheNeuroprotective AgentsPeripheral Nervous System DiseasesGlucosidesAdenosineParkinson DiseaseAnimalsMethylationMaleDisease Models, AnimalMice, Inbred C57BLMiceProto-Oncogene Proteins c-aktPolyphenols

Stichwörter der Autor:innen

Cistanche tubulosaParkinson's diseasem6A methylationperipheral neuropathy

Substanzen

Neuroprotective AgentsacteosideGlucosidesProto-Oncogene Proteins c-aktAdenosineN-methyladenosinePolyphenols

Autor:innen und Institutionen

  • Department of Pharmacy, The Second Affiliated Hospital, Xinjiang Medical University, Urumqi, China.
  • Information and Big Data Management Center, Affiliated Cancer Hospital, Xinjiang Medical University, Urumqi, China.
  • Xinjiang Medical University, Urumqi, China.
  • Department of Pharmacy, The First Affiliated Hospital, Xinjiang Medical University, Urumqi, China.

ORCID-Profile: Yatan Li

Förderung

  • Xinjiang Uygur Autonomous Region Science and Technology Department- Tianshan Innovation Team Program Project
  • Xinjiang Uygur Autonomous Region Science and Technology Department- Natural Science Foundation

Zitieren

APA

Li, Y., Jia, W., Hu, J., Zhang, B., Qi, X., Yang, J., & Yang, X. (2025). Cistanche tubulosa improves peripheral neuropathy in MPTP ‐induced PD mice based on regulation of m6A methylation. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.70039

Vancouver

Li Y, Jia W, Hu J, Zhang B, Qi X, Yang J, et al. Cistanche tubulosa improves peripheral neuropathy in MPTP ‐induced PD mice based on regulation of m6A methylation. Animal Models and Experimental Medicine. 2025. doi:10.1002/ame2.70039

BibTeX
@article{Li2025,
  author = {Li, Yatan and Jia, Wei and Hu, Junhua and Zhang, Borui and Qi, Xinxin and Yang, Jianhua and Yang, Xinling},
  title = {Cistanche tubulosa improves peripheral neuropathy in MPTP ‐induced PD mice based on regulation of m6A methylation},
  journal = {Animal Models and Experimental Medicine},
  year = {2025},
  doi = {10.1002/ame2.70039}
}
Kostenlos starten →